The influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype
Source abstract
Abstract
This study reports on the ability of poly(ethylene glycol) diacrylate (PEGDA) hydrogel scaffolds with pendant integrin-binding GRGDSP peptides (RGD-gels) to support the re-differentiation of cultured vascular smooth muscle cells (SMCs) toward a contractile phenotype. Human coronary artery SMCs were seeded on RGD-gels, hydrogels with other extracellular matrix derived peptides, fibronectin (FN) and laminin (LN). Differentiation was induced on RGD-gels with low serum medium containing soluble heparin, and the differentiation status was monitored by mRNA expression, protein expression, and intracellular protein organization of the contractile smooth muscle markers, smooth muscle alpha-actin, calponin, and SM-22alpha. RGD-gels supported a rapid induction (2.7- to 25-fold up-regulation) of SMC marker gene mRNA, with expression levels that were equivalent to FN and LN controls. Marker protein levels mirrored the changes in mRNA expression, with levels on RGD-gels indistinguishable from FN and LN controls. Furthermore, these markers co-localized in stress fibers within SMCs on RGD-gels suggesting the recapitulation of a contractile apparatus within the cells. These results indicate that SMCs cultured on RGD-bearing hydrogels can re-differentiate toward a contractile phenotype suggesting this material is an excellent candidate for further development as a bioactive scaffold that regulates SMC phenotype.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cell Adhesion Molecules Research · Connective tissue disorders research · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Growing a living blood vessel: insights for the second hundred years10.1016/j.biomaterials.2007.07.048 ↗
2. A blood vessel model constructed from collagen and cultured vascular cells10.1126/science.2934816 ↗
3. Functional arteries grown in vitro10.1126/science.284.5413.489 ↗
4. Human tissue-engineered blood vessels for adult arterial revascularization10.1038/nm1364 ↗
5. Regulation of arterial smooth muscle growth
6. The smooth muscle cell in culture10.1152/physrev.1979.59.1.1 ↗
7. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype10.1152/japplphysiol.01114.2004 ↗
8. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells10.1016/S0741-5214(98)70326-X ↗
9. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration10.1006/excr.1998.4138 ↗
10. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells10.1002/(SICI)1097-4652(199707)172:1<69::AID-JCP8>3.0.CO;2-B ↗
11. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells10.1161/01.RES.81.1.17 ↗
12. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells10.1161/01.RES.0000111805.09592.D8 ↗
13. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase10.1074/jbc.273.44.28860 ↗
14. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro10.1161/01.ATV.11.4.892 ↗
15. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue10.1038/13671 ↗
16. Mechanical influences on vascular smooth muscle cell function10.1097/00004872-199816121-00011 ↗
17. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells10.1083/jcb.107.1.307 ↗
18. Effect of extracellular matrix proteins on vascular smooth muscle cell phenotype10.1006/cbir.1995.1019 ↗
19. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently10.1007/BF00306112 ↗
20. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype10.1006/excr.1993.1016 ↗
21. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype10.1016/0012-1606(89)90052-3 ↗
22. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering10.1016/S0142-9612(02)00176-X ↗
23. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
24. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering10.1016/S0142-9612(01)00051-5 ↗
25. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels10.1002/jbm.a.20112 ↗
26. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels10.1089/ten.2006.12.2695 ↗
27. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells10.1016/j.biomaterials.2006.05.012 ↗
28. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides10.1016/j.biomaterials.2004.02.012 ↗
29. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds10.1002/jbm.10042 ↗
30. Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts10.1007/s10439-006-9099-3 ↗
31. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule10.1038/309030a0 ↗
32. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition10.1016/S0142-9612(99)00158-1 ↗
33. Human endothelial cell interaction with biomimetic surfactant polymers containing peptide ligands from the heparin binding domain of fibronectin10.1089/ten.2005.11.226 ↗
34. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen10.1016/S0021-9258(20)89455-1 ↗
35. Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein10.1021/bi00435a014 ↗
36. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor10.1021/bi00396a004 ↗
37. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells10.1074/jbc.M405100200 ↗
38. Disruption of integrin alpha 5 beta 1 signaling does not impair PDGF-BB-mediated stimulation of the extracellular signal-regulated kinase pathway in smooth muscle cells10.1002/(SICI)1097-4652(199707)172:1<109::AID-JCP12>3.0.CO;2-7 ↗
39. Adhesion receptors of vascular smooth muscle cells and their functions10.1016/S0008-6363(01)00399-6 ↗
40. Val-ala-pro-gly, an elastin-derived non-integrin ligand: smooth muscle cell adhesion and specificity10.1002/jbm.a.10110 ↗
41. Beamish JA, Zhu J, Kottke-Marchant K, Marchant RE. The effects of monoacrylated poly(ethylene glycol) on the properties of poly(ethylene glycol) diacrylate hydrogels used for tissue engineering. J Biomed Mater Res, in press.